PROVIDER PROFILE · NPI 1841289931

Fabio VolterraM.D.

PRACTICEHOWARD W BRUCKNER MD PCSee all providers at this practice →

Hematology-OncologyBronx, NYI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

6,885

Unique beneficiaries

—

Total services

34,676

Distinct HCPCS

Medicare payment

$405K

Peer benchmark

Total Medicare services vs. 628 Hematology-Oncology providers in NY — top quintile (cohort median 883).

PRESCRIBING · PART D · 2024

Total Rx claims

2,750

Beneficiaries

—

Total drug cost

$10.0M

Distinct drugs

Brand share

48.6%

Top prescribed drugs

Letrozole299 claims

Anastrozole247 claims

Darbepoetin Alfa In Polysorbat162 claims

Exemestane153 claims

Lenalidomide116 claims

QUALITY · MIPS · 2024

Final MIPS score

100.0

Quality

15.8

Cost

75.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

1.05%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Fabio Volterra's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Bioreference Health, Llc Clinical Laboratory · Elmwood Park, NJ	164	1,703
Neogenomics Laboratories Inc Clinical Laboratory · Ramsey, NJ	13	193
Avi Retter Hematology-Oncology · Bronx, NY	13	58

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history